Headlines

Novartis trial for breast cancer inhibitor produce 'compelling' and 'landmark' results

'Compelling and landmark' results will ‘fundamentally change’ the journey of patients with stage 2 and 3 early breast cancer, specifically those in need of new, well-tolerated options to prevent their cancer from coming back.

Amgen’s Lumakras data and research shows positive results across CodeBreaK clinical trial program

Research has reinforced the efficacy of Lumakras (sotorasib), a small molecule inhibitor in advanced non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC).

Paid for and in partnership with Lonza Small Molecules

The opportunity to de-risk drug development through PBPK

No company wants to progress a molecule through to the clinic only to suffer a bad readout. PBPK modeling services allow companies to predict what absorption challenges may arise in trials, and plan ways to mitigate them.

Evotec receives grant from Open Philanthropy for discovery of RNA-targeting Henipavirus therapeutics

The development of small molecule antivirals that target viral RNA in Henipaviruses will benefit from a $1.7million grant from Open Philanthropy, a philanthropic funder prioritizing global health and wellbeing.

Urgent need for the continued development of targeted treatment for NSCLC after study 'shows potential'

There is an urgent need for more targeted treatment options for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), although first-line treatment has shown potential in a clinical study.

Encouraging results for Parkinson's Disease drug in Biovie study as more patients retain sufficient muscle control

Encouraging clinical data has been released by Biovie, a company developing drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease.

Levolta Pharmaceuticals and Tabuk enter licensing and distribution agreement for osteoarthritis treatment

Pennsylvania-based Levolta Pharmaceuticals has entered into an exclusive licensing and distribution agreement with Saudi Arabia company, Tabuk Pharmaceutical Manufacturing Company to start commercializing a therapy for osteoarthritis (OA).

Global Industry News

Hot Topics

Spotlight

Women in Science: How Medable’s Pamela Tenaerts is democratizing clinical trials

Single tablet treatment on the horizon for pulmonary arterial hypertension

Priority review granted by FDA for 'landscape changing' colorectal cancer drug

Study finds AstraZeneca drug given alongside chemo shows 'strong improvement' for advanced lung cancer patients

UK missing out on being a 'life-sciences superpower' as participant numbers plummet due to lack of incentives

Gilead Sciences and Arcus Biosciences expand to include inflammation research programs

New treatment for skin condition associated with chronic kidney disease

Relieving the itch - new treatment for CKD-associated pruritus in adults on haemodialysis

Headlines

Novartis trial for breast cancer inhibitor produce 'compelling' and 'landmark' results

Amgen’s Lumakras data and research shows positive results across CodeBreaK clinical trial program

The opportunity to de-risk drug development through PBPK

Evotec receives grant from Open Philanthropy for discovery of RNA-targeting Henipavirus therapeutics

Urgent need for the continued development of targeted treatment for NSCLC after study 'shows potential'

Encouraging results for Parkinson's Disease drug in Biovie study as more patients retain sufficient muscle control

Levolta Pharmaceuticals and Tabuk enter licensing and distribution agreement for osteoarthritis treatment

Global Industry News

Providence Therapeutics partners with University Health Network for mRNA development

Lonza strengthens ADC offering with Synaffix acquisition

invoX Pharma increases investment in pHion Therapeutics to develop mRNA vaccines

BenevolentAI progresses BEN-34712 for ALS treatment

Hot Topics

Patient recruitment - what the problems are and how Greenphire is tackling them

Cumulus Neuroscience completes enrollment for Alzheimer's multi-site study

Michael J Fox Foundation chooses platform to help with Parkinson's research

Modern clinical trial needs of small and emerging biotech companies addressed by new partnership

Interview: Harnessing data for effective patient retention strategies

Vicore patent issued and positive trial results for IPF patients announced

Spotlight

Follow us

Most popular News

Products

Webinars

Featured Suppliers

Outsourcing-Pharma

Resources